rs4917014
From SNPedia
| Orientation | plus |
| Stabilized | plus |
| Make rs4917014(G;G) |
| Make rs4917014(G;T) |
| Make rs4917014(T;T) |
| Reference | GRCh38 38.1/141 |
| Chromosome | 7 |
| Position | 50266267 |
| is a | snp |
| is | mentioned by |
| dbSNP | rs4917014 |
| dbSNP (classic) | rs4917014 |
| ClinGen | rs4917014 |
| ebi | rs4917014 |
| HLI | rs4917014 |
| Exac | rs4917014 |
| Gnomad | rs4917014 |
| Varsome | rs4917014 |
| LitVar | rs4917014 |
| Map | rs4917014 |
| PheGenI | rs4917014 |
| Biobank | rs4917014 |
| 1000 genomes | rs4917014 |
| hgdp | rs4917014 |
| ensembl | rs4917014 |
| geneview | rs4917014 |
| scholar | rs4917014 |
| rs4917014 | |
| pharmgkb | rs4917014 |
| gwascentral | rs4917014 |
| openSNP | rs4917014 |
| 23andMe | rs4917014 |
| SNPshot | rs4917014 |
| SNPdbe | rs4917014 |
| MSV3d | rs4917014 |
| GWAS Ctlg | rs4917014 |
| GMAF | 0.309 |
| Max Magnitude | 0 |
| ? | (G;G) (G;T) (T;T) | 28 |
|---|---|---|
|
| ||
| GWAS snp | |
|---|---|
| PMID | [PMID 19838193] |
| Trait | Systemic lupus erythematosus |
| Title | Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus |
| Risk Allele | A |
| P-val | 3E-23 |
| Odds Ratio | 1.39 [1.30-1.47] |
[PMID 20516000] TNIP1, SLC15A4, ETS1, RasGRP3 and IKZF1 are associated with clinical features of systemic lupus erythematosus in Chinese Han population
[PMID 20680283] Down-regulated expression of IKZF1 mRNA in peripheral blood mononuclear cells from patients with systemic lupus erythematosus
| GWAS snp | |
|---|---|
| PMID | [PMID 24097068 ]
|
| Trait | HDL cholesterol |
| Title | Discovery and refinement of loci associated with lipid levels. |
| Risk Allele | G |
| P-val | 1E-8 |
| Odds Ratio | .02 [NR] unit increase |
[PMID 25672763] IKZF1, a new susceptibility gene for cold medicine-related Stevens-Johnson syndrome/toxic epidermal necrolysis with severe mucosal involvement
[PMID 31149782] Polymorphisms in MAPK9 (rs4147385) and CSF1R (rs17725712) are associated with the development of inhibitors in patients with haemophilia A in North China.
